Results 151 to 160 of about 5,991,558 (223)

A review on 5‐aminosalicylic acid colon‐targeted oral drug delivery systems

International journal of pharmaceutics, 2019
Site‐specific colon drug delivery is a practical approach for the treatment of local diseases of the colon with several advantages such as rapid onset of action and reduction of the dosage of the drug as well as minimization of harmful side effects.
Hossein Shahdadi Sardo, Farinaz Saremnejad, Sara Bagheri, A. Akhgari, H. Afrasiabi Garekani, F. Sadeghi   +5 more
semanticscholar   +1 more source

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis

Iranian Journal of Basic Medical Sciences, 2019
Objective(s): This study is aimed to design and synthesize a prodrug of 5-aminosalicylic acid and evaluate its ameliorative effect on experimental ulcerative colitis (UC).
Yan Yan, F. Ren, Pengchong Wang, Ying Sun, Jianfeng Xing   +4 more
semanticscholar   +1 more source

Remission induction, maintenance, and endoscopic outcome with oral 5‐aminosalicylic acid in intestinal Behçet's disease

Journal of Gastroenterology and Hepatology, 2019
Oral 5‐aminosalicylic acid (5‐ASA) is recommended for the therapy of mild to moderate intestinal Behçet's disease (BD). However, the induction remission efficacy and endoscopic outcomes of 5‐ASA are unknown. We investigated remission induction at 8 weeks,
Hiroto Kinoshita, H. Nishioka, A. Ikeda, Kyoko Ikoma, Y. Sameshima, H. Ohi, M. Tatsuno, J. Kouyama, C. Kawamoto, T. Mitsui, Y. Tamura, Y. Hashimoto, M. Nishio, T. Ogashiwa, Y. Saigusa, S. Maeda, H. Kimura, R. Kunisaki, K. Koike   +18 more
semanticscholar   +1 more source

5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism

Cellular and Molecular Life Sciences, 2022
Ling Huang, Junping Zheng, Guangjun Sun, Huabing Yang, Xiongjie Sun, Xiaowei Yao, Aizhen Lin, Hongtao Liu   +7 more
semanticscholar   +1 more source

A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid(5-ASA): an anti-ulcer and anti-oxidant drug

InflammoPharmacology, 2021
Mohammad Beiranvand
semanticscholar   +1 more source

Glucose ester derivatives of aminosalicylic acids*

Journal of the American Pharmaceutical Association (Scientific ed.), 1955
Glucose esters of 4‐ and 5‐aminosalicylic acid were obtainable by reaction of the benzyloxynitrobenzoic acid chlorides with diacetone glucose, followed by catalytic hydrogenation of the nitro groups. Conversion of the amines to hydrochlorides removed one or both of the acetone groups from the glucose.
W O, FOYE, E G, FELDMANN
openaire   +2 more sources

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

New England Journal of Medicine, 1987
K. Schroeder, W. Tremaine, D. M. Ilstrup
semanticscholar   +1 more source

5-Aminosalicylic acid.

Nihon rinsho. Japanese journal of clinical medicine, 2019
Despite the emergence of new biological therapies that aim for mucosal healing as a new therapeutic target, the importance of 5-ASA formulations in the standard treatment for inflammatory bowel diseases, particularly ulcerative colitis, remains unchanged.
Tomoya, Iida, Kei, Onodera, Hiroshi, Nakase   +2 more
openaire   +1 more source

Para-aminosalicylic acid

Tuberculosis, 2008
openaire   +4 more sources

Amino Acid Derivatives of Aminosalicylic Acids

Journal of Pharmaceutical Sciences, 1965
W, Hoek, J, Ebels, J, Strating
openaire   +2 more sources